| Oct 21 |
Bone Biologics Appoints Phillip T. Meikle to its Board of Directors
|
| Sep 17 |
Why Intel Shares Are Trading Higher By Around 7%; Here Are 20 Stocks Moving Premarket
|
| Aug 28 |
LifeNet launches newest bone allograft gel with Johnson & Johnson
|
| Aug 12 |
Bone Biologics files to sell 1.62M shares of common stock for holders
|
| Aug 12 |
BBLG: Controls Costs and Advances Trials
|
| Aug 2 |
Bone Biologics to raise $2.1M through exercise of warrants
|
| Aug 2 |
Bone Biologics Announces Exercise of Warrants for $2.1 Million Gross Proceeds
|
| Jul 11 |
OTC Markets Hosts Virtual Investor Presentation with Jeff Frelick, CEO and President of Bone Biologics, and Deina Walsh, CFO, with Brad Sorensen, Senior Analyst at Zacks SCR
|
| Jun 20 |
First patients treated in Bone Biologics spinal fusion trial
|
| Jun 20 |
First Two Patients Treated in Pilot Clinical Study with Bone Biologics’ NB1 Bone Graft Device in Spine Fusion
|
